Is Age Just a Number? Outcomes of Simultaneous Pancreas‐Kidney Transplantation in Patients ≥60 Years—A Contemporary SRTR Analysis

Documenti analoghi

• Long‐Term Outcomes of Belatacept Versus Tacrolimus Following T‐Cell Depleting Induction in Adult Kidney Transplantation
  di: Laura E. Newton, et al.
  Pubblicazione: (2025)
• Solid Organ Malignancy After Pancreas Transplantation: A Four Decade Single‐Center Experience
  di: Michael G. Megaly, et al.
  Pubblicazione: (2025)
• Emerging National Trends in Normothermic Regional Perfusion for Simultaneous Pancreas–Kidney Transplantation
  di: Raphaël M. J. Fischer, et al.
  Pubblicazione: (2025)
• Posttransplant Lymphoproliferative Disease Following Pancreas Transplantation: A 40 Year Single‐Center Experience
  di: Abraham J. Matar, et al.
  Pubblicazione: (2024)
• Steroid Withdrawal Versus Maintenance in Simultaneous Pancreas–Kidney Transplantation: Long‐Term Outcomes in a Single‐Center Retrospective Cohort
  di: Raphael P. H. Meier, et al.
  Pubblicazione: (2025)